Abstract
It has been reported that circRNAs play an important regulatory role in the progression of colorectal cancer (CRC). However, the molecular role of circ_0001821 in CRC development is unclear. In this study, we aimed to investigate the regulatory role and molecular mechanisms of circ_0001821 in CRC. Reverse transcription-quantitative PCR and western blot assays were used to detect the expression of circ_0001821, miR-600 and isochorismatase domain containing 1 (ISOC1) in CRC tissues as well as its cell lines. Colony formation assay and EDU assay were used to detect the proliferative capacity of cells. Transwell assay was used to assess cell migration and invasion ability. Flow cytometry was used to analyze cell apoptosis. ELISA was used to measure the glycolytic capacity of cells. Dual-luciferase reporter assay and RNA pull-down assay were used to analyze the relationships between circ_0001821, miR-600 and ISOC1. Animal experimentation was used to validate the functional study of circ_0001821 in vivo. Immunohistochemistry (IHC) of Ki67 staining analysis was conducted to assess tumor growth. Circ_0001821 and ISOC1 were significantly increased in CRC tissues and its cell lines, and miR-600 was significantly decreased in CRC tissues and its cell lines. Silencing circ_0001821 inhibited cell proliferation, migration, invasion and glycolytic capacity, while inducing apoptosis. And it could inhibit tumor growth in vivo. Circ_0001821 could act as a sponge for miR-600 to regulate CRC processes. ISOC1 was identified as a downstream regulator of miR-600, also miR-600 could regulate the expression of ISOC1. In addition, circ_0001821 could regulate ISOC1 expression changes through miR-600. Mechanistically, either miR-600 inhibitor or overexpression of ISOC1 could reverse the effects of knockdown of circ_0001821 on cell biological properties. Circ_0001821 regulated the developmental process of CRC through miR-600/ISOC1 axis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Colorectal cancer (CRC) is a common malignant disease and an important problem that has seriously endangered the health of the population worldwide (Bonney et al. 2021; Henderson et al. 2021; Kordahi et al. 2021). In addition, CRC is the second most important contributor to death due to cancer (Ferlay et al. 2015; Sun et al. 2019). The disease is also affected by lifestyle habits, diet, living environment, and genetic factors (Jung et al. 2021; Stefani et al. 2021). The number of male patients with CRC is much higher than that of female patients (Njor et al. 2021; Wekha et al. 2021). The age of CRC incidence is increasing year by year, and the incidence is becoming more intensive in middle and old age (Alyabsi et al. 2021; Lazarova and Bordonaro 2021). CRC has a good prognosis if it can be detected earlier and treated surgically (Li et al. 2021). If the disease is already at an advanced stage, it can be treated with surgery, but the postoperative complications are also very frightening and directly related to the mortality of CRC (Bonney et al. 2021; Henderson et al. 2021; Kok et al. 2021; Zhong et al. 2021). However, the molecular mechanism of CRC in the pathogenesis was not clear. Therefore, our study aimed to discover biomolecular markers of CRC that could be better, earlier and more precise.
Circular RNAs (circRNAs) are a large class of novel non-coding RNAs. CircRNAs are stably expressed in cells and have stable closed-loop structures that are not easily degraded (Chen et al. 2021a). They attract much attention in the current research field because of their structural peculiarities. Some studies have reported that circRNAs are dysregulated in many cancers and have important regulatory roles (Bi et al. 2019; Wang et al. 2018). Besides, DNA methylation plays an important role in various biological processes in prokaryotes and eukaryotes, and circRNAs are formed by reverse splicing of the corresponding host genes and can therefore be regulated by methylation (Chen and Yang 2015; Xing et al. 2014). On the other hand, microRNAs (miRNAs) are also a hot topic of current research, as they are easily detected in cells or body fluids and also have important regulatory roles (Fonseca et al. 2021; Raut et al. 2021). There are many reports that circRNAs can act as sponges of miRNAs and co-regulate the progression of cancer. For example, circ-ZKSCAN1, which was significantly dysregulated and reduced in expression in bladder cancer, was a potent molecular bio-marker, in addition, circ-ZKSCAN1 could further regulate the progression of bladder cancer by acting as a sponge for miR-1178 (Bi et al. 2019); circ_0008305 had decreased expression in lung cancer and could also act as a sponge for miR-429 and miR-200b to further regulate lung cancer progression (Wang et al. 2018). Song et al. showed that circ_0001821 expression was significantly upregulated in CRC (Song et al. 2021), but the specific function of circ_0001821 in the development of CRC is unclear. In the study by Zhang et al. showed that miR-600 expression was dysregulated and significantly reduced in CRC (Zhang et al. 2017). However, the regulatory network of circ_0001821/miR-600 axis in CRC was not clear, and we aimed to investigate the regulatory role of circ_0001821/miR-600 axis in CRC.
Circ_0001821 first appeared in the study of Wang et al. and its expression was significantly dysregulated in human lung adenocarcinoma and squamous cell carcinoma (Wang et al. 2019). However, whether circ_0001821 is dysregulated in CRC and the potential biomolecular pathogenesis of circ_0001821 in CRC progression were unknown. No functional studies of circ_0001821 in CRC were available at this stage. In our present study, we first examined the expression of circ_0001821 in CRC and further investigated the specific functions of circ_0001821 in the development of CRC. Our results suggested that circ_0001821 might be a new therapeutic target in the diagnosis and treatment of CRC.
Materials and Methods
Tissue Specimens
All CRC tissue samples as well as normal tissue samples for this study were obtained from Shannxi Provincial People's Hospital. All patients signed a written informed consent before the procedure was performed. In addition, all tissues were placed in liquid nitrogen immediately after removal and then frozen in a − 80 °C refrigerator. The study was approved by the Shannxi Provincial People's Hospital Ethics Committee.
Cell Culture
Human normal colonic epithelial cells (NCM460; #BNCC339288) was purchased from BeNa Culture Collection (Beijing, China) and CRC cell lines (SW620 and HCT116; #CL-0225B and #CL-0096) were purchased from procell (Wuhan, China). The medium used for all cells was RPMI 1640 (Invitrogen, Carlsbad, CA, USA) and 10% fetal bovine serum (FBS; Invitrogen) was added to the medium. In addition, an incubator containing 5% CO2 and 37 °C was used as the culture condition for all cell lines.
Cell Transfections
Small interference RNA against circ_0001821 (si-circ_0001821) and matched negative control (si-NC) were provided by Geneseed (Guangzhou, China). MiR-600 mimic (miR-600; #miR10003268-1-5), mimic NC (miR-NC; #miR1N0000001-1-5), miR-600 inhibitor (anti-miR-600; #miR20003268-1-5) and inhibitor NC (anti-miR-NC; #miR2N0000001-1-5) were provided by Ribobio (Guangzhou, China). Isochorismatase domain containing 1 (ISOC1) overexpression vector (ISOC1) and blank vector control (pcDNA) were also constructed by Ribobio. Cells were transfected with vectors or oligonucleotides using Lipofectamine 3000 reagent (#L3000015; Invitrogen).
Reverse Transcription-Quantitative PCR (RT-qPCR)
TRizol (#15596018; Invitrogen) was used for lysis of total RNA in all tissues as well as in all cell lines. The concentration of extracted total RNA was then measured and recorded using a UV spectrophotometer (Xipu, Shanghai, China). The extracted total RNA was further reversely transcribed to cDNA using a 1st Strand cDNA Synthesis Kit (#11119ES60; Yeasen, Shanghai, China) or miRNA 1st Strand cDNA Synthesis Kit (#11148ES10; Yeasen). Finally, PCR reactions were performed using SYBR Green mix (#11202ES03; Yeasen). Among them, U6 and β-actin were used as internal references, normalized and calculated by the 2−ΔΔCt method. Primer sequences are listed in Table 1.
Colony Formation Assay
SW620 and HCT116 cells transfected with plasmids were inoculated in 96-well plates (5 × 103 cells/well). After the cells were grown stably against the wall, the medium was replaced every two days. After culturing cells for 12 days, the medium was discarded and washed with PBS. The cell colonies were then stained with crystal violet (#A100528-0025; Sangon, Shanghai, China), and then manually counted and recorded after imaging using an inverted microscope.
EDU Assay
The proliferation ability of the cells was tested using the EDU cell proliferation assay kit (#C10310-1; Ribobio). Firstly, SW620 and HCT116 cells transfected with plasmids were inoculated in 24-well plates (8 × 104 cells/well), and after the cells were grown stably, EDU reagent was added to the cells and incubated for a total of 3 h with gentle shaking. The nuclei were stained using DAPI reagent (#DA0001; Leagene, Shanghai, China). Finally, the cells were placed under an inverted fluorescence microscope for imaging processing. The number of EDU positive cells on the pictures was then counted and recorded for analysis.
Transwell Assay
The migration and invasion abilities of the cells were assayed by transwell assay, and the chambers coated without or with Matrigel (Corning Incorporated, Corning, NY, USA) were used to evaluate cell migration or invasion, respectively. SW620 and HCT116 cells transfected with plasmids in serum-free medium were inoculated into the upper chamber. Then medium with 10% FBS was added in the lower chamber. Finally, the upper and lower chambers were placed together for co-culture. After waiting for 24 h, the cells that migrated or invaded into the lower chamber were stained with crystal violet, then images were acquired using an inverted fluorescence microscope, and finally the pictures were counted and recorded.
Flow Cytometry
Apoptosis was detected using the Annexin V-FITC/PI Apoptosis Detection Kit (#CA1020; Solarbio, Beijing, China). Plasmid-transfected SW620 and HCT116 were inoculated into 60-mm dishes (106 cells/dish), and after 48 h of cell culture, 5 µL of Annexin V-FITC and 5 µL of PI were added to each dish and incubated for 30 min under light-protected conditions.
Glucose Uptake, Lactate Production Levels Assay
The glycolytic capacity of the cells was assayed using a glucose uptake assay kit (#MAK083; Sigma-Aldrich, St. Louis, MO, USA) and lactate kit (#MAK064; Sigma-Aldrich). Cells were inoculated in 60-mm dishes (106 cells/dish), and glucose consumption and lactate production in the cells were assayed after 48 h stable cell culture. Finally, all data were statistically analyzed.
Western Blot Assay
Total proteins were extracted from CRC tissues, normal tissues and all cell lines using RIPA Lysis Buffer (#P0013C; Beyotime, Shanghai, China). The denatured proteins were then separated using SDS-PAGE (#P0670; Beyotime), and after electrophoresis, the protein bands were transferred to PVDF membranes (#FFP33; Beyotime). The PVDF membranes were placed in skimmed milk for containment treatment. Excess skim milk was further washed off the PVDF membranes using TBST buffer and co-incubated with primary antibodies. All primary antibodies were: proliferating cell nuclear antigen (anti-PCNA, ab29, Abcam, Cambridge, MA, USA), matrix metallopeptidase 2 (anti-MMP2, ab92536, Abcam, 1/2000), BCL2 associated X, apoptosis regulator (anti-Bax, ab32503, Abcam, 1/5000), hexokinase 2 (anti-HK2, ab209847, Abcam, 1/1000), beta-actin gene (anti-β-actin, ab8226, Abcam, 1/5000) and isochorismatase domain containing 1 (anti-ISOC1, orb400332, Biorbyt, Wuhan, China, 1/1000). The PVDF membranes were incubated overnight at 4 °C and washed again using TBST buffer at the end of the incubation. The PVDF membranes were then incubated with matched secondary antibodies (ab205718 and ab205719, Abcam, 1/20000). Finally, the PVDF membrane was color developed using ECL (#32132; Unique, Beijing, China), then photographed and stored.
Dual-Luciferase Reporter Assay
The wild-type (WT) sequence segment of circ_0001821 and ISOC1 containing the putative miR-600 binding site, as well as the mutant-type (MUT) sequence segment of circ_0001821 and ISOC1 containing the mutated binding site of miR-600 were respectively synthesized and cloned into pmirGLO vector (Promega, Madison, WI, USA) to form circ_0001821WT, circ_0001821MUT, ISOC1-3'UTRWT and ISOC1-3'UTRMUT reporter vectors. The above plasmids were then co-transfected with miR-NC or miR-600 into SW620 and HCT116 cells. The assay of luciferase activity was performed after 48 h of co-culture. Finally, statistical analysis was performed.
RNA Pull-Down Assay
The interaction between circ_0001821 and miR-600 was analyzed using RNA pull-down kit (#KT103-01; Gzscbio, Guangzhou, China). Biotin-labeled miR-600 (Bio-miR-600) and miR-NC (Bio-miR-NC) provided by Ribobio were first transfected into SW620 and HCT116 cells. Then they were co-incubated with streptavidin magnetic beads. After incubation, total RNA was harvested by eluting the RNA-binding complex from the magnetic beads. Then the RNA was extracted and the enrichment of circ_0001821 was detected and normalized.
Animal Experimentation
In this study, all mice (Balb/c, 6-week-old) were purchased from Vital River (Beijing, China). Short hairpin RNA targeting circ_0001821 (sh-circ_0001715) and control (sh-NC) were synthesized and inserted into lentiviral vector by Geneseed, followed by lentiviral packaging. SW620 cells after lentiviral infection were inoculated by subcutaneous injection into nude mice. The volume of the tumors (length × width 2 × 1/2) was measured at 7-day intervals, and then on day 35, after the volume measurements were completed, the mice were executed and the mass of the tumors was weighed. All animal experiments were approved by the Shannxi Provincial People's Hospital Research Animal Care and Use Committee.
Immunohistochemistry (IHC)
The expression of Ki-67 in mouse tumor tissues was assessed using IHC. Tumor tissues were removed and then washed with PBS, followed by sectioning. The tumor tissues were then incubated with primary antibody Ki-67 (anti-Ki-67, 1:200, Abcam) overnight at 4 °C. Then the secondary antibody was added and incubated for 30 min at 37 °C. Finally, the sections were stained with hematoxylin (#H9627; Sigma-Aldrich) and sealed. Finally, image acquisition was performed using a microscope.
Statistical Analysis
All experiments were performed with three replications. All data were counted, analyzed and then plotted using GraphPad Prism 8 (GraphPad, La Jolla, CA, USA). Two independent sets of data were analyzed using the Student's T-test. More than two groups were analyzed using one-way ANOVA or two-way ANOVA. The correlation analysis among circ_0001821, miR-600 and ISOC1 was performed using Pearson’s correlation analysis. P values were considered statistically significant when they were less than 0.05.
Results
Circ_0001821 was UpRegulated in CRC Tissues
To investigate the role played by circ_0001821 in the process of CRC, we analyzed the structure of circ_0001821. The analysis showed that circ_0001821 was chromosome 8 located on its host gene TCONS_00015354 (chr8: 128902834-128903244) and was composed of 1 exon (Fig. 1A). Further, the expression of circ_0001821 was examined in the tissues of 44 CRC patients. The results showed that the expression of circ_0001821 was significantly upregulated in CRC tissues compared to normal tissues (Fig. 1B). Finally, we examined the expression in CRC cell lines, and the results showed that the expression of circ_0001821 was also significantly increased in SW620 and HCT116 cells compared with normal NCM460 cells (Fig. 1C). In summary, the expression of circ_0001821 was elevated in both CRC tissues and its cell lines.
Silencing circ_0001821 Inhibited Cell Proliferation, Migration, Invasion and Glycolytic Capacity as Well as Induced Apoptosis in CRC Cell Lines
We further investigated the biomolecular role played by circ_0001821 in CRC cell lines. We first examined the knockdown efficiency of circ_0001821 in CRC cell lines, the RT-qPCR showed that the expression of circ_0001821 was significantly reduced in CRC cells after si-circ_001821 transfection (Fig. 2A). Immediately after silencing circ_0001821, the proliferation ability of the SW620 and HCT116 cells was significantly decreased (Fig. 2B, C). Further, we assessed the migration and invasion ability of the cells, transwell assay results showed that the migration ability and invasion abilities of the cells were significantly inhibited after silencing circ_0001821 (Fig. 2D, E). Also, we examined that the apoptosis of cells was significantly increased after silencing circ_0001821 (Fig. 2F). In addition, the glucose consumption and lactate production of the cells were also decreased after circ_0001821 silencing (Fig. 2G, H). Last but not least, to confirm the results of the above assay, we also examined the marker proteins of proliferation (PCNA), metastasis (MMP2), apoptosis (Bax) and glycolysis (HK2) and obtained consistent results (Fig. 2I, J). Overall, silencing circ_0001821 in CRC cell lines inhibited proliferation, migration, invasion and glycolysis, while apoptosis was promoted.
Circ_0001821 Acted as a Sponge for miR-600
To further investigate the molecular mechanism of circ_0001821 in CRC development, we predicted the downstream targeting regulators of circ_0001821 using circinteractome website (https://circinteractome.nia.nih.gov/api/v2/mirnasearch?circular_rna_query=hsa_circ_0001821&mirna_query=&submit=miRNA+Target+Search). The results showed that miR-600 might be a downstream target of circ_0001821. Circ_0001821 and miR-600 had corresponding binding sites, and to further investigate the relationship between them, we mutated the binding sites of circ_0001821 and miR-600 (Fig. 3A). We examined the expression of miR-600 in CRC tissues and cell lines, and miR-600 expression was significantly reduced (Fig. 3B, C). Dual-luciferase reporter assay displayed a decrease of luciferase activity in SW620 and HCT116 cells with circ_0001821WT and miR-600 mimic cotransfection (Fig. 3D, E). RNA pull-down assay displayed that high abundance of circ_0001821 was enriched by Bio-miR-600 probe relative to Bio-miR-NC probe (Fig. 3F, G). Finally, the correlation analysis showed a significant negative correlation between circ_0001821 and miR-600 (Fig. 3H). Overall, the expression of miR-600 was reduced in CRC tissues as well as CRC cell lines, and in addition there was an interaction between circ_0001821 and miR-600.
The Regulatory Effect of Silencing circ_0001821 on Cells Could be Counteracted by miR-600 Inhibitor in CRC Cell Lines
Firstly, we examined the knockdown efficiency of miR-600 in SW620 and HCT116 cells, and the results showed that miR-600 expression was reduced (Fig. 4A). Colony formation assay and EDU assay on cell proliferation ability showed that silencing circ_0001821 significantly inhibited cell proliferation, but was counteracted by the inhibitor of miR-600 (Fig. 4B, C). In addition, the effect of silencing circ_0001821 on cell migration and invasion abilities as well as apoptosis was reversed by miR-600 inhibitor (Fig. 4D–F). Further we explored the glycolytic capacity of SW620 and HCT116 cells, the results showed that silencing circ_0001821 inhibited cellular glucose consumption and lactate production, but these were counteracted by low expression of miR-600 (Fig. 4G, H). Finally, we quantified the marker proteins for the above functions and showed that the inhibitory effects of PCNA, MMP9 and HK2 inhibited by silencing circ_0001821 and the promotive effects of Bax were reversed by the low expression of miR-600 (Fig. 4I, J). In summary, the effects of low expression of circ_0001821 on the biological properties of cells could be reversed by miR-600 inhibitor.
ISOC1 was the Target Gene of miR-600
We explored the regulatory network of circ_0001821/miR-600 in cells in more depth. Bioinformatics software (TargetScan: https://www.targetscan.org/cgi-bin/targetscan/vert_72/targetscan.cgi?species=Human&gid=&mir_sc=&mir_c=&mir_nc=&mir_vnc=&mirg=miR-600) was used to detect the downstream target genes of miR-600. The results showed that ISOC1 might be a downstream regulator of miR-600. The binding sites of miR-600 and ISOC1 are shown in Fig. 5A. In addition, the expression of ISOC1 was significantly increased in CRC tissues as well as in its cell lines (Fig. 5B–D). The results of dual-luciferase reporter assay showed that miR-600 and ISOC1 interacted with each other (Fig. 5E, F). The protein expression of ISOC1 was significantly increased after inhibition of miR-600 (Fig. 5G). In addition, the protein expression of ISOC1 was decreased with the decrease of circ_0001821, but the protein expression of ISOC1 increased significantly after the addition of miR-600 inhibitor (Fig. 5H, I). Correlation analysis showed that miR-600 and ISOC1 expression were negatively correlated, and circ_0001821 and ISOC1 expression were significantly positively correlated (Fig. 5J, K). On all accounts, miR-600 could regulate the expression of ISOC1, and in addition, circ_0001821 could regulate the expression of ISOC1 through miR-600.
The Regulatory Effect of circ_0001821 Knockdown on Cell Biological Properties Could be Reversed by Overexpression of ISOC1
We investigated the regulatory network of circ_0001821 in CRC development in more depth. First, we overexpressed ISOC1 in SW620 and HCT116 cells, and the results showed that the expression of ISOC1 was significantly increased (Fig. 6A). Silencing circ_0001821 inhibited the proliferative capacity of cells, which was reversed by overexpression of ISOC1 (Fig. 6B, C). In addition, the inhibitory effects of low expression of circ_0001821 on both the migration and invasive abilities of cells were counteracted by high expression of ISOC1 (Fig. 6D, E). The apoptotic rate of cells was increased with the decrease of circ_0001821, but this effect was inhibited again after overexpression of ISOC1 in the cells (Fig. 6F). In addition, silencing circ_0001821 inhibited the glycolytic capacity of cells, but this was counteracted by increased expression of ISOC1 (Fig. 6G, H). Finally, we examined the above-mentioned signature proteins and obtained the same results (Fig. 6I, J). To sum up, the effects of silencing circ_0001821 on cell biological functions could be reversed by high expression of ISOC1.
Circ_0001821 Silencing Hampered Tumor Growth In Vivo
To verify the role of circ_0001821 in vitro, we investigated the function of circ_0001821 in vivo. The results of the mouse xenograft tumor model assay showed that the tumor volume and weight were significantly suppressed in the sh-circ_0001821 group compared to the control group (Fig. 7A, B). The results of IHC analysis showed that the expression of Ki-67 was significantly reduced in the sh-circ_0001821 group compared with the control group (Fig. 7C). Finally, we examined the expression of circ_0001821, miR-600 and ISOC1 in sh-circ_0001821, and the results showed that the expression of circ_0001821 and ISOC1 was significantly reduced, while the expression of miR-600 was significantly increased (Fig. 7D–G). The above results suggested that circ_0001821 inhibited tumor growth in vivo. It further indicates that circ_0001821 plays an active role in the growth of tumors in vivo.
Discussion
Earlier or more sensitive biomarker to diagnose CRC is very good for CRC patients (Yang et al. 2017). A growing number of studies have shown that circRNAs were significantly dysregulated and had a very important regulatory role in many diseases, such as hepatocellular carcinoma (Chen et al. 2021c), cardiovascular disease (Zhang et al. 2021), non-small-cell lung cancer (Chen et al. 2021b), prostate cancer (Mugoni et al. 2021) and breast cancer (Wu et al. 2021). In our study, we determined the expression of circ_0001821 in CRC tissues and its cell lines, and investigated more deeply the biological function of circ_0001821 played in CRC development. It provided a valid biomarker for better confirming the diagnosis of CRC.
Another important aspect was that circRNAs could regulate cancer progression and played a regulatory role in cancer progression. For instance, the expression of circ_002178 was increased in CRC, and silencing circ_002178 inhibited the proliferative capacity and glycolytic capacity of cells (Xu et al. 2021); circIPO11 was significantly increased in hepatocellular carcinoma, and in addition, silencing circIPO11 inhibited the ability of cancer cells to migrate and metastasize (Gu et al. 2021). A significant increase in circ_0001821 expression in CRC tissues has been reported (Song et al. 2021). Consistent results were obtained in our study, circ_0001821 expression was significantly increased in both CRC tissues and cell lines. We further investigated the function of circ_0001821 in CRC cell lines. We silenced circ_0001821 in CRC cell lines and the results showed that knockdown of circ_0001821 significantly inhibited the proliferation, migration, invasion and glycolytic capacity of cancer cells as well as induced apoptosis. Our findings further suggested that circ_0001821 promoted the developmental process of CRC.
CircRNAs that have binding sites for miRNAs may act as sponges for miRNAs to play regulatory roles (Qu et al. 2021). In addition, more and more studies had demonstrated that miRNAs regulated the expression of downstream target genes (Bi et al. 2019; Zhang et al. 2021), and circRNAs further regulated the expression changes of downstream genes through miRNAs (Bi et al. 2019). In this study, our experimental results showed that circ_0001821 could bind and interact with miR-600. Our results in functional assays showed that the effects of circ_0001821 silencing on the biological functions of cells could be reversed by miR-600 inhibitor. The above results suggested that circ_0001821 regulated the pathogenic process of CRC through miR-600. Of note, previous studies reported that RNA-binding protein could also act as “miRNA sponge” to sequester miRNAs and thus mediate the translation of downstream functional genes (Poria et al. 2016). For instance, HuR RNA-binding protein sequestered miR-21 to regulate the translation of PDCD4 gene (Poria et al. 2016). RNA-binding proteins that may govern miR-600 expression should be investigated to further understand the role of miR-600 in CRC.
ISOC1 is a hydrolase and belongs to protein-coding genes (Gao et al. 2020). Many studies have shown that ISOC1 was positively correlated in tumor progression. ISOC1 has been reported to be highly expressed in lung cancer (Shi et al. 2021), gastric cancer (Zhao et al. 2020), colon cancer (Gao et al. 2020) and pancreatic cancer (Cheng et al. 2019) and also promotes the cancer process and growth of cancer cells. These findings suggested that ISOC1 might be an oncogene. Therefore, we concluded that ISOC1 was a downstream target gene of miR-600 by bioinformatics analysis. Furthermore, circ_0001821 could regulate the expression of ISOC1 through miR-600. It was further concluded by rescue assay that the effect of circ_0001821 silencing on CRC cell lines could be counteracted by overexpression of ISOC1.
To sum up, in this study, we demonstrated the upregulation of circ_0001821 expression in CRC samples. Silencing circ_0001821 suppressed cell proliferation, migration, invasion and glycolytic capacity, while promoted apoptosis in CRC cell lines. Circ_0001821 could further regulate ISOC1 expression by sponging miR-600. Mechanistically, the effects of circ_0001821 silencing on cell biological properties could be reversed by miR-600 inhibitor or overexpression of ISOC1. These results suggested that circ_0001821 could be used as a molecular marker for CRC and that this study might provide a useful theoretical basis for earlier and more effective confirmation of CRC diagnosis.
Data Availability
The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.
References
Alyabsi M, Algarni M, Alshammari K (2021) Trends in colorectal cancer incidence rates in Saudi Arabia (2001–2016) using saudi national registry: early- versus late-onset disease. Front Oncol 11:730689. https://doi.org/10.3389/fonc.2021.730689
Bi J, Liu H, Dong W, Xie W, He Q, Cai Z et al (2019) Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer 18(1):133. https://doi.org/10.1186/s12943-019-1060-9
Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P et al (2021) Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol 6(11):933–946. https://doi.org/10.1016/S2468-1253(21)00219-3
Chen LL, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12(4):381–388. https://doi.org/10.1080/15476286.2015.1020271
Chen J, Gu J, Tang M, Liao Z, Tang R, Zhou L et al (2021a) Regulation of cancer progression by circRNA and functional proteins. J Cell Physiol. https://doi.org/10.1002/jcp.30608
Chen S, Zhou L, Ran R, Huang J, Zheng Y, Xing M et al (2021b) Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro. Thorac Cancer. https://doi.org/10.1111/1759-7714.14191
Chen X, She P, Wang C, Shi L, Zhang T, Wang Y et al (2021c) Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2. J Clin Lab Anal 35:e23991. https://doi.org/10.1002/jcla.23991
Cheng L, Zhao Y, Tang M, Luo Z, Wang X (2019) Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro. Oncol Lett 17(5):4263–4270. https://doi.org/10.3892/ol.2019.10082
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359-386. https://doi.org/10.1002/ijc.29210
Fonseca A, Ramalhete SV, Mestre A, Pires das Neves R, Marreiros A, Castelo-Branco P et al (2021) Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression. Aging (albany NY) 13(18):21991–22029. https://doi.org/10.18632/aging.203556
Gao B, Zhao L, Wang F, Bai H, Li J, Li M et al (2020) Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3beta pathway. Carcinogenesis 41(8):1123–1133. https://doi.org/10.1093/carcin/bgz188
Gu Y, Wang Y, He L, Zhang J, Zhu X, Liu N et al (2021) Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Mol Cancer 20(1):132. https://doi.org/10.1186/s12943-021-01435-2
Henderson RH, French D, Maughan T, Adams R, Allemani C, Minicozzi P et al (2021) The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. Lancet Gastroenterol Hepatol 6(9):709–722. https://doi.org/10.1016/S2468-1253(21)00147-3
Jung SY, Sobel EM, Pellegrini M, Yu H, Papp JC (2021) Synergistic effects of genetic variants of glucose homeostasis and lifelong exposures to cigarette smoking, female hormones, and dietary fat intake on primary colorectal cancer development in African and Hispanic/Latino American Women. Front Oncol 11:760243. https://doi.org/10.3389/fonc.2021.760243
Kok DE, Arron MNN, Huibregtse T, Kruyt FM, Bac DJ, van Halteren HK et al (2021) Association of habitual preoperative dietary fiber intake with complications after colorectal cancer surgery. JAMA Surg. https://doi.org/10.1001/jamasurg.2021.2311
Kordahi MC, Stanaway IB, Avril M, Chac D, Blanc MP, Ross B et al (2021) Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer. Cell Host Microbe 29(10):1589–1598. https://doi.org/10.1016/j.chom.2021.08.013
Lazarova D, Bordonaro M (2021) Multifactorial causation of early onset colorectal cancer. J Cancer 12(22):6825–6834. https://doi.org/10.7150/jca.63676
Li X, Xiong Z, Xie M, Huang Q, Jin L, Yin S et al (2021) Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer. J Gastrointest Oncol 12(4):1470–1481. https://doi.org/10.21037/jgo-21-61
Mugoni V, Ciani Y, Nardella C, Demichelis F (2021) Circulating RNAs in prostate cancer patients. Cancer Lett 524:57–69. https://doi.org/10.1016/j.canlet.2021.10.011
Njor SH, Rasmussen M, Friis-Hansen L, Andersen B (2021) Varying fecal immunochemical test screening cut-offs by age and gender: a way to increase detection rates and reduce number of colonoscopies. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2021.09.038
Poria DK, Guha A, Nandi I, Ray PS (2016) RNA-binding protein HuR sequesters microRNA-21 to prevent translation repression of proinflammatory tumor suppressor gene programmed cell death 4. Oncogene 35(13):1703–1715. https://doi.org/10.1038/onc.2015.235
Qu J, Yuan C, Jia Q, Sun M, Jiang M, Zuo F (2021) CircularRNA_0119872 regulates the microRNA-582–3p/E2F transcription factor 3 pathway to promote the progression of malignant melanoma. Clinics (sao Paulo) 76:e3036. https://doi.org/10.6061/clinics/2021/e3036
Raut JR, Schottker B, Holleczek B, Guo F, Bhardwaj M, Miah K et al (2021) A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction. Nat Commun 12(1):4811. https://doi.org/10.1038/s41467-021-25067-8
Shi J, Yang F, Zhou N, Jiang Y, Zhao Y, Zhu J et al (2021) Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development. Transl Lung Cancer Res 10(3):1444–1456. https://doi.org/10.21037/tlcr-21-219
Song Y, Cao P, Li J (2021) Plasma circular RNA hsa_circ_0001821 acts as a novel diagnostic biomarker for malignant tumors. J Clin Lab Anal 35:e24009. https://doi.org/10.1002/jcla.24009
Stefani C, Miricescu D, Stanescu S II, Nica RI, Greabu M, Totan AR et al (2021) Growth factors, PI3K/AKT/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now? Int J Mol Sci 22(19):10260. https://doi.org/10.3390/ijms221910260
Sun D, Chen Y, Fang JY (2019) Influence of the microbiota on epigenetics in colorectal cancer. Natl Sci Rev 6(6):1138–1148. https://doi.org/10.1093/nsr/nwy160
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T et al (2018) Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer. Mol Cancer 17(1):140. https://doi.org/10.1186/s12943-018-0889-7
Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu Y et al (2019) RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer 18(1):134. https://doi.org/10.1186/s12943-019-1061-8
Wekha G, Ssewante N, Iradukunda A, Jurua M, Nalwoga S, Lanyero S et al (2021) Colorectal cancer in Uganda: a 10-year, facility-based, retrospective study. Cancer Manag Res. 13:7697–7707. https://doi.org/10.2147/CMAR.S334226
Wu H, Xu J, Gong G, Zhang Y, Wu S (2021) CircARL8B contributes to the development of breast cancer via regulating miR-653-5p/HMGA2 Axis. Biochem Genet 59(6):1648–1665. https://doi.org/10.1007/s10528-021-10082-7
Xing XW, Tang F, Wu J, Chu JM, Feng YQ, Zhou X et al (2014) Sensitive detection of DNA methyltransferase activity based on exonuclease-mediated target recycling. Anal Chem 86(22):11269–11274. https://doi.org/10.1021/ac502845b
Xu Y, Wang C, Lu X, Qi R, Wang X, Zhao J (2021) CircRNA_002178 as a ceRNA promotes the development of colorectal cancer by regulating miR-542-3p/CREB1. Am J Transl Res 13(9):10038–10055
Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z et al (2017) Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets 21(11):1063–1075. https://doi.org/10.1080/14728222.2017.1389900
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin Q et al (2017) miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines. Oncol Lett 13(3):1789–1796. https://doi.org/10.3892/ol.2017.5654
Zhang L, Yu R, Li C, Dang Y, Yi X, Wang L (2021) Circ_0026416 downregulation blocks the development of colorectal cancer through depleting MYO6 expression by enriching miR-545-3p. World J Surg Oncol 19(1):299. https://doi.org/10.1186/s12957-021-02407-y
Zhang L, Wang Y, Yu F, Li X, Gao H, Li P (2021) CircHIPK3 plays vital roles in cardiovascular disease. Front Cardiovasc Med. 8:733248. https://doi.org/10.3389/fcvm.2021.733248
Zhao JQ, Li XN, Fu LP, Zhang N, Cai JH (2020) ISOC1 promotes the proliferation of gastric cancer cells by positively regulating CDK19. Eur Rev Med Pharmacol Sci 24(22):11602–11609. https://doi.org/10.26355/eurrev_202011_23803
Zhong Y, Long T, Gu CS, Tang JY, Gao LF, Zhu JX et al (2021) MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly. Cell Death Differ. https://doi.org/10.1038/s41418-021-00813-z
Acknowledgements
Not applicable
Funding
This work was supported by Shaanxi Provincial Key Research and Development Program 2021SF-125.
Author information
Authors and Affiliations
Contributions
Conceptualization and Methodology: XG and YZ; Formal analysis and Data curation: YZ and XC; Validation and Investigation: CL and XG; Writing—original draft preparation and Writing—review and editing: CL, XG and YZ; Approval of final manuscript: all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Consent for Publication
Patients agree to participate in this work.
Ethical Approval and Consent to Participate
The present study was approved by the ethical review committee of Shannxi Provincial People's Hospital. Written informed consent was obtained from all enrolled patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, C., Gao, X., Zhao, Y. et al. High Expression of circ_0001821 Promoted Colorectal Cancer Progression Through miR-600/ISOC1 Axis. Biochem Genet 61, 410–427 (2023). https://doi.org/10.1007/s10528-022-10262-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-022-10262-z